These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11501128)
1. [Effects of hyperbaric oxygen therapy on the changes in serum sIL-2R and Fn in severe burn patients]. Xu N; Li Z; Luo X Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 May; 15(3):220-3. PubMed ID: 11501128 [TBL] [Abstract][Full Text] [Related]
2. Characterization of early thermal burns and the effects of hyperbaric oxygen treatment: a pilot study. Chong SJ; Kan EM; Song C; Soh CR; Lu J Diving Hyperb Med; 2013 Sep; 43(3):157-61. PubMed ID: 24122191 [TBL] [Abstract][Full Text] [Related]
3. [Dynamic observation of the fibronectin content in plasma and subeschar tissue following burn]. Chen GH Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1990 Mar; 6(1):14-6, 74. PubMed ID: 2357627 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
5. Adjunctive hyperbaric oxygen therapy in severe burns: Experience in Taiwan Formosa Water Park dust explosion disaster. Chiang IH; Chen SG; Huang KL; Chou YC; Dai NT; Peng CK Burns; 2017 Jun; 43(4):852-857. PubMed ID: 28034667 [TBL] [Abstract][Full Text] [Related]
6. [Serum soluble interleukin-2 receptor levels in uveitis]. Xie C; Huang X; Zhou H; Yang P Yan Ke Xue Bao; 1998 Jun; 14(2):64-5. PubMed ID: 12580032 [TBL] [Abstract][Full Text] [Related]
7. [The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders]. Xu J; Wang B Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):82-4. PubMed ID: 10921108 [TBL] [Abstract][Full Text] [Related]
8. [Changes in serum contents of interleukin-6 and interleukin-10 and their relation with occurrence of sepsis and prognosis of severely burned patients]. Zhou H; Tu JJ; Huang Y; Chen XG; Deng YJ Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):111-5. PubMed ID: 22781322 [TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis. Arranz O; Ara J; Rodríguez R; Saurina A; Mirapeix E; Darnell A J Nephrol; 2000; 13(1):59-64. PubMed ID: 10720216 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma]. Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo. Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356 [TBL] [Abstract][Full Text] [Related]
12. [Changes of interleukin-2 and soluble interleukin-2 receptor serum level and multiple organ dysfunction syndrome in severely traumatic patients]. He Z; Wang S; Su Z; Huang Y; Yang J Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):492-3. PubMed ID: 11829898 [TBL] [Abstract][Full Text] [Related]
14. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer. Naumnik W; Chyczewska E Folia Histochem Cytobiol; 2001; 39 Suppl 2():185-6. PubMed ID: 11820599 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of sIL-2R, TNF-α and PCT for Sepsis Infection in Patients With Closed Abdominal Injury Complicated With Severe Multiple Abdominal Injuries. Zhai GH; Zhang W; Xiang Z; He LZ; Wang WW; Wu J; Shang AQ Front Immunol; 2021; 12():741268. PubMed ID: 34745113 [TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977 [TBL] [Abstract][Full Text] [Related]